ContractIndemnification Agreement • July 27th, 2017
Contract Type FiledJuly 27th, 2017INDEMNIFICATION AGREEMENT (“AGREEMENT”) Protocol Number: AR-105-002 (“Study”) Principal Investigator: XXXXX (“Principal Investigator”) Institution: Krajska nemocnice T. Bati, a.s. (“Institution”) Protocol Title: “Placebo-controlled, double-blind, randomized study of Aerucin® as adjunct therapy to antibiotics in the treatment of P. aeruginosa pneumonia” (“Protocol”) Study Drug: Aerucin® (aerubumab, AR-105) (“Study Drug”) Whereas, Aridis Pharmaceuticals, Inc. (“Sponsor”) has authorized Medpace Clinical Research, LLC (“Medpace”), a contract research organization, to perform study management activities for the Study and to enter into and execute written agreements with the research sites participating in the Study to govern the performance of the Study; Whereas, as Sponsor is not a party to the agreement between Institution and Medpace, Institution has requested a written agreement setting forth the circumstances under which Sponsor will indemnify Institution for its activities in connecti